NCT05335720View on ClinicalTrials.gov

Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)

NACompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

July 19, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

April 8, 2020

Conditions

Skin Graft ScarSplit-Thickness Skin Graft (STSG)

Interventions

DRUG

rhEGF

EASYEF® spray 50 mcg, sprayed twice a day for 14 days.

Trial Locations (1)

10410

RSPAD Gatot Soebroto, Central Jakarta

Sponsors

Collaborators (1)

Equilab International

All Listed Sponsors

collaborator

Equilab International

UNKNOWN

lead

PT. Daewoong Infion

INDUSTRY